The primary clinical objective of this study is to evaluate the safety and effectiveness of a physician-modified, fenestrated and branched aortic endoprosthesis for the treatment of thoracoabdominal aortic aneurysms (TAAAs). The goal of the primary analysis is to demonstrate both the safety and effectiveness of using a physician-modified fenestrated Cook Zenith Alpha Thoracic Endovascular Graft as compared to previously published results of open surgical replacement of the aneurysmal aorta.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
30 day survival
Timeframe: 30 days
Major Adverse Events (MAE) at 30 days following surgery
Timeframe: 30 days
Treatment success at 12 months following surgery
Timeframe: 12 months
Technical success at 12 months following surgery
Timeframe: 12 months